Literature DB >> 10481909

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

R M Chemelli1, J T Willie, C M Sinton, J K Elmquist, T Scammell, C Lee, J A Richardson, S C Williams, Y Xiong, Y Kisanuki, T E Fitch, M Nakazato, R E Hammer, C B Saper, M Yanagisawa.   

Abstract

Neurons containing the neuropeptide orexin (hypocretin) are located exclusively in the lateral hypothalamus and send axons to numerous regions throughout the central nervous system, including the major nuclei implicated in sleep regulation. Here, we report that, by behavioral and electroencephalographic criteria, orexin knockout mice exhibit a phenotype strikingly similar to human narcolepsy patients, as well as canarc-1 mutant dogs, the only known monogenic model of narcolepsy. Moreover, modafinil, an anti-narcoleptic drug with ill-defined mechanisms of action, activates orexin-containing neurons. We propose that orexin regulates sleep/wakefulness states, and that orexin knockout mice are a model of human narcolepsy, a disorder characterized primarily by rapid eye movement (REM) sleep dysregulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481909     DOI: 10.1016/s0092-8674(00)81973-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  789 in total

1.  Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep.

Authors:  E Pinzar; Y Kanaoka; T Inui; N Eguchi; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

Authors:  P Bourgin; S Huitrón-Résendiz; A D Spier; V Fabre; B Morte; J R Criado; J G Sutcliffe; S J Henriksen; L de Lecea
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 3.  Psychogenomics: opportunities for understanding addiction.

Authors:  E J Nestler
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

Review 4.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

5.  What we learned from narcolepsy of others.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2003-02       Impact factor: 4.599

6.  Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.

Authors:  Dan Georgescu; Venetia Zachariou; Michel Barrot; Michihiro Mieda; Jon T Willie; Amelia J Eisch; Masashi Yanagisawa; Eric J Nestler; Ralph J DiLeone
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

7.  Risk-assessment and coping strategies segregate with divergent intrinsic aerobic capacity in rats.

Authors:  Paul R Burghardt; Shelly B Flagel; Kyle J Burghardt; Steven L Britton; Lauren Gerard-Koch; Stanley J Watson; Huda Akil
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

8.  Role of adenosine and the orexinergic perifornical hypothalamus in sleep-promoting effects of ethanol.

Authors:  Rishi Sharma; Pradeep Sahota; Mahesh M Thakkar
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

9.  Connexin 43-Mediated Astroglial Metabolic Networks Contribute to the Regulation of the Sleep-Wake Cycle.

Authors:  Jerome Clasadonte; Eliana Scemes; Zhongya Wang; Detlev Boison; Philip G Haydon
Journal:  Neuron       Date:  2017-08-31       Impact factor: 17.173

Review 10.  Sex differences in circadian timing systems: implications for disease.

Authors:  Matthew Bailey; Rae Silver
Journal:  Front Neuroendocrinol       Date:  2013-11-25       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.